These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 14567545)
1. Discovery and evaluation of terephthalic acid derivatives as potent alpha4beta1 integrin antagonists. Müller G; Albers M; Hessler G; Lehmann TE; Okigami H; Tajimi M; Bacon K; Rölle T J Enzyme Inhib Med Chem; 2003 Aug; 18(4):309-12. PubMed ID: 14567545 [TBL] [Abstract][Full Text] [Related]
2. Discovery and evaluation of piperidinyl carboxylic acid derivatives as potent alpha(4)beta(1) integrin antagonists. Müller G; Albers M; Fischer R; Hessler G; Lehmann TE; Okigami H; Tajimi M; Bacon K; Rölle T Bioorg Med Chem Lett; 2001 Dec; 11(23):3019-21. PubMed ID: 11714601 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4. Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179 [TBL] [Abstract][Full Text] [Related]
14. Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. Garmy-Susini B; Jin H; Zhu Y; Sung RJ; Hwang R; Varner J J Clin Invest; 2005 Jun; 115(6):1542-51. PubMed ID: 15902308 [TBL] [Abstract][Full Text] [Related]
15. Contrasting roles for domain 4 of VCAM-1 in the regulation of cell adhesion and soluble VCAM-1 binding to integrin alpha4beta1. Woodside DG; Kram RM; Mitchell JS; Belsom T; Billard MJ; McIntyre BW; Vanderslice P J Immunol; 2006 Apr; 176(8):5041-9. PubMed ID: 16585601 [TBL] [Abstract][Full Text] [Related]
16. VLA-4 blockade by natalizumab inhibits sickle reticulocyte and leucocyte adhesion during simulated blood flow. White J; Krishnamoorthy S; Gupta D; Lancelot M; Moore N; Sarnaik S; Hobbs WE; Light DR; Hines P Br J Haematol; 2016 Sep; 174(6):970-82. PubMed ID: 27291690 [TBL] [Abstract][Full Text] [Related]
17. The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives. Schlesinger M; Schmitz P; Zeisig R; Naggi A; Torri G; Casu B; Bendas G Thromb Res; 2012 May; 129(5):603-10. PubMed ID: 22099706 [TBL] [Abstract][Full Text] [Related]
18. Pyridone derivatives as potent and selective VLA-4 integrin antagonists. Witherington J; Bordas V; Gaiba A; Green PM; Naylor A; Parr N; Smith DG; Takle AK; Ward RW Bioorg Med Chem Lett; 2006 Apr; 16(8):2256-9. PubMed ID: 16455247 [TBL] [Abstract][Full Text] [Related]
19. The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin. Schlesinger M; Roblek M; Ortmann K; Naggi A; Torri G; Borsig L; Bendas G Thromb Res; 2014 May; 133(5):855-62. PubMed ID: 24636486 [TBL] [Abstract][Full Text] [Related]